Basic Information
| LncRNA/CircRNA Name | ASB16-AS1 |
| Synonyms | NA |
| Region | GRCh38_17:44175973-44186717 |
| Ensemble | ENSG00000267080 |
| Refseq | NR_049729 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | apoptosis | Drug | ||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | glioma |
| ICD-0-3 | NA |
| Methods | qPCR, Western blot |
| Sample | glioma tissues,cell lines(U251,U87MG ) |
| Expression Pattern | up-regulated |
| Function Description | ASB16-AS1 Expression Levels Are Significantly Upregulated in Human Glioma Tissues and Correlate with WHO Grade. |
| Pubmed ID | 30949502 |
| Year | 2019 |
| Title | Long Noncoding RNA ASB16-AS1 Promotes Proliferation, Migration, and Invasion in Glioma Cells. |
External Links
| Links for ASB16-AS1 | GenBank HGNC NONCODE |
| Links for glioma | OMIM COSMIC |